Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Patients with type 2 diabetes aged 45-79; -After dietary control or oral antidiabetic drugs, only the maintenance dose is taken, and the variety and dose of drugs need maintain within half a year, while the fasting blood glucose = 6.1 mmol /L or the postprandial blood glucose = 7.8 mmol /L at 2 hours; -Have the habit of drinking milk; -On the basis of full understanding of the trial, the informed consent is voluntarily signed.
Exclusion criteria
Exclusion criteria: -Have type 1 diabetes; -Pregnant or lactating women; -Lactose intolerance, allergy to dairy products or formula ingredients; -Serious complications of major organs such as heart, liver, kidney, or other serious diseases and psychosis; -Taking glucocorticoids or other drugs that affect blood glucose; -Patients with diabetes ketosis, acidosis and infection in the last 3 months of the study; -Other nutritional preparations that may affect the test results are being used; -Participate in other interventional clinical trials within 3 months before screening; -Other circumstances that the study leader considers to be unsuitable for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprandial blood glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| glycosylated hemoglobin;24-hour dietary review survey (3 days);Blood routine, blood biochemistry and urine routine; | — |
Countries
China